Miriam P. van der Meulen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Miriam P. van der Meulen has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Ernst J. Kuipers
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
4 shared publications - Iris Lansdorp-Vogelaar
Department of Public Health Erasmus University Medical Center Rotterdam The Netherlands
4 shared publications - Monique E. van Leerdam
Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands
3 shared publications - Harry J. de Koning
Department of Public Health Erasmus MC, University Medical Center Rotterdam Rotterdam The Netherlands
2 shared publications Lieke Hol
Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands
2 shared publications- Manon C. W. Spaander
Department of Gastroenterology and Hepatology Erasmus University Medical Center Rotterdam The Netherlands
2 shared publications
Latest Publications
- Open Access
- 3 May 2023
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 23 (2)
Managing the Increasing Burden of Atrial Fibrillation through Integrated Care in Primary Care: A Cost-Effectiveness Analysis
Integrated care for patients with atrial fibrillation (AF) in primary care reduced mortality compared to usual care. We assessed the cost-effectiveness of this approach. Dutch primary care practices were randomised to provide integrated care for AF patients or usual care. A cost-effectiveness analysis was performed from a societal perspective with a 2-year time horizon to estimate incremental costs and Quality Adjusted Life Years (QALYs). A sensitivity analysis was performed, imputing missing questionnaires for a large group of usual care patients. 522 patients from 15 intervention practices were compared to 425 patients from 11 usual care practices. No effect on QALYs was seen, while mean costs indicated a cost reduction between €865 (95% percentile interval (PI) –€5730 to €3641) and €1343 (95% PI –€6534 to €3109) per patient per 2 years. The cost-effectiveness probability ranged between 36% and 54%. In the sensitivity analysis, this increased to 95%-99%. Results should be interpreted with caution due to missing information for a large proportion of usual care patients. The higher costs from extra primary care consultations were likely outweighed by cost reductions for other resources, yet this study doesn’t give sufficient clarity on the cost-effectiveness of integrated AF care.
- 3 May 2023
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 23 (2)
Open AccessManaging the Increasing Burden of Atrial Fibrillation through Integrated Care in Primary Care: A Cost-Effectiveness Analysis
Integrated care for patients with atrial fibrillation (AF) in primary care reduced mortality compared to usual care. We assessed the cost-effectiveness of this approach. Dutch primary care practices were randomised to provide integrated care for AF patients or usual care. A cost-effectiveness analysis was performed from a societal perspective with a 2-year time horizon to estimate incremental costs and Quality Adjusted Life Years (QALYs). A sensitivity analysis was performed, imputing missing questionnaires for a large group of usual care patients. 522 patients from 15 intervention practices were compared to 425 patients from 11 usual care practices. No effect on QALYs was seen, while mean costs indicated a cost reduction between €865 (95% percentile interval (PI) –€5730 to €3641) and €1343 (95% PI –€6534 to €3109) per patient per 2 years. The cost-effectiveness probability ranged between 36% and 54%. In the sensitivity analysis, this increased to 95%-99%. Results should be interpreted with caution due to missing information for a large proportion of usual care patients. The higher costs from extra primary care consultations were likely outweighed by cost reductions for other resources, yet this study doesn’t give sufficient clarity on the cost-effectiveness of integrated AF care.
- 1 August 2015
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 13 (8) , 1464-1471.e4
Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia
- 1 August 2015
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 13 (8) , 1464-1471.e4
Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia
- 1 April 2015
- Published by Elsevier in Gastroenterology
- Vol. 148 (4) , S-756-756
Mo1977 Monitoring the Dutch National Colorectal Cancer Screening Program: Results of the First 6 Months and an Analysis of Measures to Prevent Waiting Lists for Colonoscopy
- 1 April 2015
- Published by Elsevier in Gastroenterology
- Vol. 148 (4) , S-756-756
Mo1977 Monitoring the Dutch National Colorectal Cancer Screening Program: Results of the First 6 Months and an Analysis of Measures to Prevent Waiting Lists for Colonoscopy
- 1 April 2015
- Published by Elsevier in Gastroenterology
- Vol. 148 (4) , S-758-758
Mo1982 Do Men and Women Need to Be Screened Differently With Faecal Immunochemical Testing? A Cost-Effectiveness Analysis
- 1 April 2015
- Published by Elsevier in Gastroenterology
- Vol. 148 (4) , S-758-758
Mo1982 Do Men and Women Need to Be Screened Differently With Faecal Immunochemical Testing? A Cost-Effectiveness Analysis
- Open Access
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Su1037 Evidence for Systematic Failure of Repeat Fecal Immunochemical Tests and Its Limited Implications for Effectiveness
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Open AccessSu1037 Evidence for Systematic Failure of Repeat Fecal Immunochemical Tests and Its Limited Implications for Effectiveness